*To the Editor*:

The hazardous effects of environmental tobacco smoke (ETS) on the lung health of small children are generally recognized. Governmental actions need improvement in decreasing worldwide smoking prevalence ([@bib1]). The global average of young men starting smoking is 40%; it is 9% for women ([@bib1]). As children are born to young families, they are often exposed to ETS. We have previously shown that maternal smoking in particular adversely affects the lung function of preschoolers with asthma ([@bib2]), and now we wanted to objectively examine whether early exposure to ETS has a long-term effect on lung function.

We enrolled 105 children (median age, 5 yr) referred to Helsinki University Hospital with multitrigger wheeze and evidence of bronchodilator response (≥35% decrease in respiratory resistance at 5 Hz \[R5\]) or exercise-induced bronchoconstriction (≥35% increase in R5), or both ([@bib3]). Exclusion criteria included the use of corticosteroids in the previous 6 months and respiratory tract infection in the preceding 2 weeks. After 10 years, 64 children participated in a follow-up visit.

We assessed the child's exposure to ETS at preschool age with urine cotinine levels, using gas chromatography ([@bib2]), as well as with a questionnaire. Cotinine is a stable metabolite of nicotine and can be used to objectively measure exposure to ETS. It is found in saliva, urine, hair, and blood a few days after exposure to ETS. We have previously presented the gas chromatographic method and the correlation between urinary cotinine levels and ETS in this particular population ([@bib2]).

Fractional exhaled nitric oxide (F[e]{.smallcaps}~NO~) and impulse oscillometry were performed following current guidelines both at enrollment and at the 10-year follow-up visit ([@bib2]--[@bib5]). Impulse oscillometry indices of interest included the total respiratory system resistance (R5) and reactance (X5) at 5 Hz, and area under reactance (AX), reflecting the capacitive component of reactance that is affected by small airway function. At the follow-up visit, lung function was also assessed by spirometry ([@bib6]), and the children underwent dosimetric bronchial provocation with methacholine including five cumulative dose steps ([@bib7]). Increased airway hyperresponsiveness was considered to be present if a ≤400-μg dose provoked at least a 20% decrease in the FEV~1~ (PD~20~FEV~1~).

A blood eosinophil percentage of ≥4% was considered eosinophilia. A wheal diameter of ≥3 mm was considered positive for skin prick tests to local aeroallergens (birch, timothy grass, meadow fescue, mugwort, *Cladosporium herbarum*, dog, cat, horse, cow, and *Dermatophagoides pteronyssinus*).

Nonnormally distributed data were analyzed using the Mann-Whitney *U* test (dichotomous comparisons), and normally distributed data with Pearson's correlation test. We analyzed data with four categories, using one-way ANOVA. Because of the lack of impulse oscillometry reference values for adolescents, the upper quartile of R5 and lower quartile of X5 were considered suggestive of obstruction. A *P* value ≤0.05 was considered statistically significant. Data were analyzed using IBM SPSS 25.0.

Parents provided written informed consent at both study visits; children provided written informed consent only at the follow-up visit. The Research Ethics Committee of the regional university hospital approved the research protocol. Statistical approaches were verified by the biostatistics department of the university. Some of the results of this study have been previously reported in the form of an abstract ([@bib8]).

In this population, current wheezing decreased during the follow-up time, whereas atopy increased ([Table 1](#tbl1){ref-type="table"}). A general decrease was observed in blood eosinophilia, F[e]{.smallcaps}~NO~, and R5 levels. A significant proportion of parents ceased smoking during the follow-up time (43%). Only one parent started smoking after enrollment. Recent asthma symptoms (during the last 2 months) were reported by 22 (34%) teenagers, and a recent need for any asthma medication (during the last 2 months) by 23 (36%). None of the teenagers reported smoking.

###### 

Demographics and Test Results of Study Patients (*n* = 64)

  Patient Characteristics and Measurements                                   Preschool          Teenage
  ------------------------------------------------------------------------ -------------- --------------------
  Age, yr, mean (range)                                                     5.62 (3--7)      14.22 (12--16)
  ISO-BMI, kg/m^2^, mean (SD)                                               22.92 (4.16)       23.1 (3.8)
  ISO-BMI \> 25 kg/m^2^, *n* (%)                                              16 (25)           15 (23)
  Wheezing during previous yr, *n* (%)[\*](#tblfn1){ref-type="table-fn"}      53 (83)            7 (11)
  Parental smoking, *n* (%)[\*](#tblfn1){ref-type="table-fn"}                 21 (33)           13 (20)
  Parental asthma, *n* (%)[\*](#tblfn1){ref-type="table-fn"}                  15 (24)           18 (28)
  Positive SPT, *n* (%)                                                       45 (70)           59 (92)
  Urine cotinine, μg/L, mean (SD)                                           2.06 (3.56)           ---
  F[e]{.smallcaps}~NO~*z*-score, mean (SD)                                  2.54 (1.57)       2.08 (2.61)
  Abnormal F[e]{.smallcaps}~NO~ (*z*-score ≥ 2 SD), *n* (%)                   36 (60)           31 (49)
  Blood eosinophils, %, mean (SD)                                           6.92 (4.76)       5.16 (4.19)
  Blood eosinophilia (≥4%), *n* (%)                                           53 (83)           34 (54)
  FEV~1~*z*-score, mean (SD)                                                    ---           −0.45 (1.16)
  Abnormal FEV~1~ (*z*-score ≤ −1.645 SD), *n* (%)                              ---              9 (14)
  R5, kPa/L/s, mean (SD)                                                    0.89 (0.22)       0.36 (0.09)
  Upper quartile R5 (R5 \< 0.451 kPa/L/s), *n* (%)                              ---              12 (8)
  X5, kPa/L/s, mean (SD)                                                    −0.27 (0.10)      −0.09 (0.03)
  Lower quartile X5 (X5 \> −0.121 kPa/L/s), *n* (%)                             ---              7 (5)
  Methacholine challenge, μg, median (IQR)                                      ---        1,709 (283--2,600)
  AHR to methacholine (PD~20~FEV~1~ ≤ 400 μg), *n* (%)                          ---             17 (27)

*Definition of abbreviations*: AHR = airway hyperresponsiveness; F[e]{.smallcaps}~NO~ = fractional exhaled nitric oxide; ISO-BMI = sex- and age-adjusted body mass index for children; IQR = interquartile range; PD~20~FEV~1~ = provocative dose causing 20% decrease in FEV~1~; R5 = respiratory resistance at 5 Hz; SPT = skin prick test; X5 = respiratory reactance at 5 Hz.

Self-reported.

Preschool cotinine levels were not associated with recent symptoms or need for medication in adolescence. Children with high urinary cotinine levels had parents with asthma (*P* = 0.046) more often than those with low levels. However, we observed that parental asthma was not connected with symptoms, need for medication, or lung function results.

Overweight (body mass index \> 25 kg/m^2^) in adolescence correlated with baseline FEV~1~/FVC (*P* = 0.025), R5--20 (*P* = 0.007), resonant frequency (*P* = 0.002), and AX (*P* = 0.014) at the same age, but not with preschool cotinine levels. Preschool urinary cotinine results correlated with F[e]{.smallcaps}~NO~ *z*-scores (*R* = 0.227; *P* = 0.009), blood eosinophils (%) (*R* = 0.496; *P* \< 0.001), baseline FEV~1~ *z*-scores (*R* = −0.219; *P* = 0.041), baseline R5 (kPa/L/s; *R* = 0.272; *P* = 0.015), baseline X5 (kPa/L/s; *R* = −0.297; *P* = 0.009), and baseline AX (kPa/L; *R* = 0.316; *P* = 0.012) in adolescence. Nevertheless, no correlation with methacholine responsiveness (PD~20~FEV~1~) or baseline FEV~1~/FVC was observed.

In the dichotomous analysis of the data, a significant association with cotinine remained with F[e]{.smallcaps}~NO~, blood eosinophilia, increased baseline R5, and decreased baseline X5. A significant association was not observed with decreased baseline FEV~1~ or decreased PD~20~FEV~1~ ([Figure 1](#fig1){ref-type="fig"}). Only the children's baseline X5 remained low (*P* = 0.020) if the parents had quit smoking before the follow-up visit compared with nonsmoking families. The adverse effects of maternal smoking only could be detected with impulse oscillometry indices, X5 (*P* = 0.003) and AX (*P* = 0.048), as well as with blood eosinophilia (*P* = 0.045). Other measures showed a similar pattern.
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The influence of overweight and preschool ETS on lung function and inflammation markers were significant but essentially different. In our study, children exposed to ETS were generally not overweight, and thus the mechanisms of lung function deficits are probably distinct. Both factors are known to be associated with lower economic status. As a result of questionnaire limitations, the confounding effect cannot be excluded.

We quantified the child's exposure to ETS at preschool age and compared it with objective measures of lung function in adolescence. Although the small sample size restricted the power of the analyses, we found long-lasting multifactorial effects of ETS on children with asthma. It is notable that the defects measurable with impulse oscillometry suggest small airway dysfunction similar to chronic obstructive pulmonary disease ([@bib9]) and persisted even when parents quit smoking during the follow-up. It is possible that the actual airway remodeling might occur in the child's epigenetic environment ([@bib10]).

In conclusion, early-life exposure to tobacco smoke causes chronic airway inflammation and defects in lung function in children with asthma. These defects are measurable even a decade later as changes in F[e]{.smallcaps}~NO~, blood eosinophil levels, impulse oscillometry, and spirometry. Smoking cessation is good; prevention is even better.
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